摘要
目的探讨高迁移率族蛋白B1(high mobility group box1,HMGB1)修饰间充质干细胞(mesenchymal stem cells,MSC)对球囊损伤大鼠颈动脉的作用及分子机制。方法 HMGB1重组腺病毒(ad5GFP-HMGB1)转染MSC后,实时定量PCR、Western blot和免疫组化法检测MSC中HMGB1、血管内皮生长因子(VEGF)、增殖细胞核抗原(PCNA)的表达水平。构建球囊损伤大鼠颈动脉模型,Evans Blue染色评价损伤血管再内皮化;ELISA检测血清中肿瘤坏死因子-α(TNF-α)和C反应蛋白(CRP)水平。结果与对照组和空载ad5GFP组比较,HMGB1修饰增加MSC中VEGF和PCNA的mRNA和蛋白表达水平(P均<0.05)。Evans Blue染色显示,与对照组(11.35±2.25)和空载ad5GFP组(36.78±3.75)比较,ad5GFP-HMGB1组(47.66±9.11)损伤血管再内皮化面积明显增加,差异均具有统计学意义(P均<0.01)。ELISA结果显示,HMGB1修饰MSC能降低颈动脉损伤大鼠血清中TNF-α和CRP的表达水平(P均<0.05)。结论 HMGB1修饰MSC对大鼠颈动脉损伤具有保护效应,其机制可能与上调VEGF和PCNA表达及抑制炎症反应有关。HMGB1可能是MSC修复内皮过程中的一个新的治疗靶点。
Objective To explore the protective effects of mesenchymal stem cells (MSC)modified by highmobility group box 1 (HMGB1) on balloon-induced carotid artery injury.Methods MSC were infected by adenoviral serotype 5 encoding recombinant green fluorescent protein (GFP) gene and HMGB1 (ad5GFP-HMGB1).The expression levels of HMGB 1,vascular endothelial growth factor (VEGF) and proliferating cell nuclear antigen (PCNA) were detected in HMGB1-modified MSC using real-time PCR,western blot and tissue immunohistochemical assays.A balloon-induced carotid artery injury model was established in rats.Reendothelialization was evaluated by Evans Blue staining,and the serum levels of tumor necrosis factor-α (TNF-α) and C-reactive protein (CRP) were assessed by ELISA assay.Results Compared with MSC group and ad5 GFP group,the expression levels of HMGB1,VEGF and PCNA were markedly increased in HMGBl-modified MSC (each P 〈 0.05).The Evans Blue staining demonstrated that the reendothelialization areas (47.66 ± 9.11)of carotid artery injury were significantly increased,compared with MSC group (11.35 ± 2.25) and ad5 GFP group (36.78 ± 3.75) (each P 〈 0.01).ELISA assay showed that the serum levels of TNF-α and CRP were decreased in group ad5GFP and ad5GFP-HMGB1 compared with MSC group(each P 〈 0.05).Conclusions Transplantation of HMGB1-modified MSC exerts a protective effect on balloon-induced carotid artery injury,which may be associated with the up-regulation of VEGF and PCNA and inhibition of inflammatory response.HMGB1 may be a new therapeutic target in the process of MSC mediated endothelial repair.
出处
《中华临床医师杂志(电子版)》
CAS
2013年第1期106-109,共4页
Chinese Journal of Clinicians(Electronic Edition)
基金
国家自然科学基金资助项目(81060014)